1. |
Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995; 39:265-92.
|
2. |
Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2005; 45:115-34.
|
3. |
Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006; 46:111-22.
|
4. |
Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt- Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007; 114:606-14.
|
5. |
Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2007; 144:260-5.
|
6. |
Gupta V, Gupta A, Gupta P, et al. Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2009; 147:148-153.e2.
|
7. |
Ishihara K, Hangai M, Kita M, et al. Acute Vogt-Koyanagi- Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology 2009; 116:1799- 807.
|
8. |
Zhao C, Zhang M, Wen X, et al. Choroidal folds in acute Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm 2009; 17:282-8.
|
9. |
Maruyama Y, Kishi S. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers Imaging 2004; 35:239-42.
|
10 |
de Smet MD, Rao NA. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2005; 140:962.
|
11 |
Tsujikawa A, Yamashiro K, Yamamoto K, et al. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2005; 139:670-7.
|
12 |
Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131:647-52.
|
13 |
Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 2001; 108:54-64.
|
14 |
Holtkamp GM, Kijlstra A, Peek R, et al. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 2001; 20:29-48.
|
15 |
Shi G, Maminishkis A, Banzon T, et al. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008; 49:4620-30.
|
16 |
Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005; 20:183-90.
|
17 |
Lertsumitkul S, Whitcup SM, Nussenblatt RB, et al. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Graefes Arch Clin Exp Ophthalmol 1999; 237:1039-45.
|
18 |
Kuo IC, Rechdouni A, Rao NA, et al. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 2000; 107:1721-8.
|
19 |
Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131:599-606.
|
20 |
Bykhovskaya I, Thorne JE, Kempen JH, et al. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 2005; 140:674-8.
|
21 |
Tugal-Tutkun I, Ozyazgan Y, Akova YA, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey : VKH in Turkey . Int Ophthalmol 2007; 27:117-23.
|
22 |
Kalluri R, Weinberg RA. The basics of epithelial-mesen- chymal transition. J Clin Invest 2009; 119:1420-8.
|
23 |
Saika S, Yamanaka O, Sumioka T, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res 2008; 27:177-96.
|